(eCALWY-1) displayed efficient energy transfer in the absence of Zn 2+ , but showed a large, 2.4-fold decrease in emission ratio upon Zn 2+ binding (Fig. 1d,e) . The Zn 2+ affinity of eCALWY-1 (K d = 2 pM at pH 7.1) was only tenfold lower than that of the CALWY sensor, showing that the interaction between the fluorescent domains was easily disrupted by zinc binding. Mutation of one of the zinc-binding cysteines in the WD4 domain (C416S) attenuated the Zn 2+ affinity 300-fold, yielding eCALWY-4 with a K d of 0.6 nM. This mutation also abrogated the binding of Cu + , which induces an interaction between the metal binding domains in eCALWY-1 (Supplementary Fig. 1 ). We subsequently fine-tuned Zn 2+ affinity by shortening the linker between the metal binding domains, yielding sensors eCALWY-1-6 that span the picomolar to nanomolar ranges in Zn 2+ affinity and display at least a twofold ratiometric change upon zinc binding (Fig. 1e) .
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Next we tested the performance of the eCALWY sensors to monitor free cytosolic Zn 2+ levels in pancreatic β cells (INS-1(832/13)), a cell type known to contain high zinc levels in granules specialized in insulin storage 9, 10 . All sensors were homogeneously expressed throughout the cytosol of the cells. We observed a large increase in emission ratio in cells expressing eCALWY-1 after addition of the membrane-permeant zinc chelator TPEN (N,N,N′,N′-tetrakis-(2-pyridylmethyl)-ethylenediamine), indicative of a decrease in cytosolic zinc (Fig. 2a) . Subsequent perifusion with 5 µM of the zinc ionophore pyrithione had little effect, but together with 100 µM ZnCl 2 the emission ratio rapidly returned to the starting level. Addition of TPEN or Zn 2+ -pyrithione did not affect the emission ratio of a nonbinding sensor variant ( Supplementary  Fig. 2 ). Moreover, we observed a consistent trend for the emission ratio at the start of the experiment, changing from a fully saturated level for eCALWY-1 to nearly unsaturated for eCALWY-6 ( Fig. 2a-g and Supplementary Fig. 3 ). We calculated the sensor occupancy as:
in which R max and R min are the steady-state emission ratios obtained after TPEN and zinc-pyrithione addition, respectively, and R start is the ratio at the start of the experiment. A plot of the sensor occupancy as a function of its K d had a sigmoidal shape that is consistent with a free Zn 2+ concentration of ~0.4 nM (Fig. 2h) . Notably, repeating these experiments in HEK293 cells showed very similar responses ( Supplementary Figs. 4,5 and Supplementary Video 1), suggesting that the ~0.4 nM level may be invariant among different cell lines. In fact, similar values have been reported using synthetic dyes in more indirect measurements on cell populations with FluoZin-3 (Invitrogen) in human colon cancer HT293 (~0.6 nM) 11 We developed genetically encoded fluorescence resonance energy transfer (fret)-based sensors that display a large ratiometric change upon Zn 2+ binding, have affinities that span the pico-to nanomolar range and can readily be targeted to subcellular organelles. using this sensor toolbox we found that cytosolic Zn 2+ was buffered at 0.4 nm in pancreatic  cells, and we found substantially higher Zn 2+ concentrations in insulincontaining secretory vesicles.
Zinc is important in many fundamental cellular processes, acting as a Lewis acid catalyst in many enzymes, having a structural function in DNA-binding proteins and acting as a modulator in neurotransmission [1] [2] [3] . At the same time, low nanomolar concentrations of free Zn 2+ can be cytotoxic, rendering zinc homeostasis a delicate balance that is not well understood. Although synthetic fluorescent sensors have been used to monitor zinc fluctuations in live cells 2, 4 , they typically lack control over subcellular localization and often have insufficient affinity to detect extremely low free Zn 2+ concentrations. Genetically encoded fluorescence resonance energy transfer (FRET)-based sensor proteins can be used to overcome these limitations 5, 6 but their application for imaging transition metal homeostasis has thus far remained underdeveloped.
The FRET sensors reported here are based on a previously developed Zn 2+ sensor (CALWY:CFP-Atox1-linker-WD4-YFP) that showed high Zn 2+ affinity (dissociation constant (K d ) = 140 fM, pH 7.5), but suffered from a small change in emission ratio (15%) 7 . CALWY consists of two metal binding domains (Atox1 and domain 4 of ATP7B (WD4)) linked via a long flexible linker, with each domain providing two cysteines to form a single tetrahedral zinc binding pocket (Fig. 1a) . First, we replaced the enhanced CFP and enhanced YFP domains with Cerulean and Citrine to improve brightness and reduce pH sensitivity of the fluorophores, respectively. Next, we improved the ratiometric response considerably by introducing mutations (S208F and V224L) on the surface of both fluorescent domains that are known to promote intramolecular complex formation 8 (Fig. 1a-d) . As a result, this enhanced CALWY Zinbo-5 (Merck Chemicals) (~1 nM) 12 . Previous studies in which researchers had tried to estimate free cytosolic Zn 2+ concentrations using protein-based sensors did not use internal calibration and/or were done outside the sensors' detection range, resulting in either very high (180 nM) or very low (5 pM) values 5, 6 .
The fact that the occupancies of all eCALWY variants could be described by a single concentration of free Zn 2+ is important because it implies that the intracellular free Zn 2+ concentration is strongly buffered and not perturbed substantially by the presence of low micromolar concentrations of the sensors. To test this buffering capacity, we grew INS-1(832/13) β-cells expressing eCALWY-4 overnight in medium containing either 100 µM EDTA or a Zn 2+ -buffer providing 5 µM of free Zn 2+ . Cells that we grew in the presence of 100 µM EDTA showed free cytosolic Zn 2+ concentrations that were similar to those of cells grown in normal medium, but we observed nanomolar or higher free Zn 2+ levels in cells grown in the presence of excess Zn 2+ (Fig. 2i,j) . Notably, when we perifused the latter cells with buffer containing 100 µM EDTA, cytosolic zinc levels rapidly decreased to ~0.4 nM, showing that these cells efficiently restore their intracellular Zn 2+ levels once excess zinc is removed (Fig. 2i,j) . We observed no decrease in cytosolic zinc for normally cultured cells after perifusion with 100 µM EDTA.
To determine whether the cytosolic environment affects the sensor K d , we calibrated the eCALWY-4 sensor in situ by perifusing cells treated with α-toxin using buffers containing different free zinc concentrations. The in situ-determined K d confirmed that the intracellular conditions were only weakly affecting the zinc affinity (Supplementary Fig. 6 ). Specificity of our sensors for Zn 2+ over biologically relevant Ca 2+ concentrations could be demonstrated by depolarizing INS-1(832/13) cells with KCl to elicit Ca 2+ influx. Despite a clear increase in cytosolic Ca 2+ to 1 µM, we observed no change in the emission in cells expressing eCALWY-5 ( Supplementary Fig. 7) .
As control over intracellular localization is a key advantage of genetically encoded sensors, we next targeted the eCALWY sensors to the insulin granules of INS-1(832/13) cells by fusing them to the C terminus of vesicle-targeted membrane protein 2 (VAMP2) 13 . As we anticipated higher free zinc concentrations in these vesicles 9 , we also used a low-affinity Zn 2+ sensor (eZinCh; K d = 8 µM at pH 7.1 and 250 µM at pH 6.0; Supplementary Fig. 8 ). eZinCh displayed a fourfold increase in emission ratio upon zinc binding and is similar to the previously reported ZinCh 14 , but contains Cerulean and Citrine as fluorescent domains. Localization studies of the vesicular-targeted Zn 2+ sensors with a granule-localized neuropeptide Y-mCherry fusion protein showed that VAMP2-eCALWY-1, VAMP2-eCALWY-6 and VAMP2-eZinCh were indeed exclusively localized in insulin-containing granules ( Fig. 3a and Supplementary Fig. 9 ). The low emission ratios observed for the eCALWY variants before stimulation suggested saturation with Zn 2+ (Fig. 3b) , whereas eZinCh appeared to be empty. No changes in emission ratio could be induced using either TPEN or Zn 2+ -pyrithione for VAMP2-eCALWY-1 and VAMP2-eZinCh, probably reflecting an inability of these agents to induce sufficient changes in the intravesicular free Zn 2+ concentration ( Supplementary  Fig. 10 ). However, we observed robust and reversible ratiometric changes for VAMP2-eZinCh upon addition of monensin ( Fig. 3b and Supplementary Video 2). This Na + /H + exchanger increases the pH of granules from approximately pH 6.0 to pH 7.1, simultaneously increasing the affinity of eZinCh and inducing Zn 2+ release from the insulin-Zn 2+ complex. We could exclude changes owing to the pH sensitivity of the fluorescent domains because Fig. 11 ) and that VAMP2-eZinCh was mostly Zn 2+ -free, thus suggesting that the free Zn 2+ concentration in these vesicles was between 1 and 100 µM.
In conclusion, we developed a new generation of Zn 2+ probes that can be used to image low concentrations of free Zn 2+ in single living cells. We found that cytosolic amounts of free Zn 2+ were buffered at ~0.4 nM, which coincides with the Zn 2+ -buffering capacity of metallothioneins 15 . Cytosolic Zn 2+ concentrations were maintained at a level sufficient to fully saturate native Zn 2+ proteins (which typically have K d values of 1-10 pM) but approximately tenfold below the lownanomolar concentrations that have been reported to inhibit several cytosolic proteins 3 . We also demonstrated that these probes can be targeted to subcellular organelles, including secretory granules. Fig. 12 ) was obtained via digestion of pUC57-eZinCh-NB and a pET28a-derived vector using NotI and NdeI, followed by ligation of the eZinCh-NB fragment into the pET28a vector. Site-directed mutagenesis was applied on pET28a-eZinCh-NB to create pET28a-eZinCh. Mutations Y39H and S208C were introduced simultaneously in both fluorescent domains using a QuikChange Multi site-directed mutagenesis kit (Stratagene; primers 1 and 2 for mutations Y39H and S208C, respectively (Supplementary Table 2) ). peZinCh was obtained via double digestion of pET28a-eZinCh using AgeI and NotI and ligation into a pECFP-1 derived vector that was digested using the same enzymes.
To create the mammalian expression vector for CALWY, multiple cloning steps were required. First, a fragment encoding for Atox1 was obtained by digestion of pET28a-CALWY (Supplementary Fig. 13 ) using SacI and BspEI and ligated into a SacI and BspEI-digested peZinCh-NB to create pCer-Atox1-L9-Cit. Next, a fragment encoding for the WD4 domain obtained from pET28a-CALWY using digestion with SacII and KpnI and ligated into pCer-Atox1-L9-Cit via the same restriction sites, yielding pCALWY. This vector was then digested with NdeI and NotI to obtain a fragment encoding for CALWY that could be ligated into an NdeI and NotI digested pET28a-CLY9 vector to yield the bacterial expression vector pET28a-CALWY. QuikChange site-directed mutagenesis (Stratagene) via the method described in ref. 8 was used to introduce the S208F and V224L mutations in the Cerulean and Citrine domains of both pET28a-CALWY and pCALWY to create pET28a-eCALWY-1 and peCALWY-1, respectively. A QuikChange Multi site-directed mutagenesis kit (Stratagene) was used together with primer 3 (Supplementary Table 2) according to manufacturers' instructions to obtain pET28a-eCALWY-4 and peCALWY-4. Bacterial and mammalian expression vectors for eCALWY-2, eCALWY-3, eCALWY-5 and eCALWY-6 were obtained via partial digestion of the flexible peptide linker using BamHI followed by religation using the method described in ref. 16 . The expression vector for the non-binding variant of eCALWY, pET28a-eCALWY-NB, was obtained using a QuikChange Multi site-directed mutagenesis kit (Stratagene) according to manufacturers' instructions (primer 4 for mutations C284S and C287S and primer 5 for mutations C413S and C416S (Supplementary  Table 2) ). The resulting vector was digested with AgeI and NotI, followed by ligation of the eCALWY-NB fragment into an AgeIand NotI-digested peCALWY to obtain the mammalian expression vector peCALWY-NB.
To create the vesicle-targeted mammalian expression plasmids, a sequence encoding for VAMP2 was cloned N-terminally of the selected zinc sensor proteins (Supplementary Fig. 14) . PCR was used to amplify the sequence encoding VAMP2 and simultaneously add sequence encoding an N-terminal SpeI site and a C-terminal NheI-site (primers 6 and 7 respectively, Supplementary Table 2 ). The VAMP2 amplicon was digested using NheI and SpeI, followed by ligation into a mammalian NheI-digested expression vector encoding for one of the sensor constructs. The correct open reading frame for all expression vectors was confirmed by DNA sequencing (Baseclear).
Expression and purification of sensor proteins. All fusion proteins were expressed in Escherichia coli BL21(DE3) (Novagen) and purified according to a published method 7 . Expression was induced using 0.1 mM IPTG, and bacteria were subsequently grown at 15 °C for 4 h (eCALWY variants) or at 25 °C overnight (eZinCh and eZinCh-NB). Cells were collected and lysed using Bugbuster (Novagen). Next, the soluble protein fraction was purified using nickel affinity chromatography and histidine tags were subsequently removed by digestion with thrombin and a second round of nickel affinity chromatography. The cleaved product was additionally purified using size-exclusion chromatography (S200 Sephacryl column, GE) in 50 mM Tris, 100 mM NaCl and 1 mM DTT (pH 7.5). Fractions containing protein were analyzed using SDS-PAGE and fractions showing a single band corresponding to the expected molecular weight were pooled, resulting in >95% pure protein samples. Typical yields after the first round of nickel affinity chromatography were ~10 mg l −1 culture for eCALWY-1-3, ~35 mg l −1 culture for eCALWY-4-6 and ~150 mg l −1 for eZinCh and eZinCh-NB.
Zinc titrations.
Zinc titrations for the eCALWY variants were performed in 150 mM Hepes, 100 mM NaCl, 1 mM DTT and 10% (vol/vol) glycerol (pH 7.1). At pH 6.0, measurements were performed using the same buffer, but using 150 mM MES instead of Hepes. DTT was used to prevent oxidation of the cysteines in the metal binding motif. For eZinCh, 150 mM MOPS, 100 mM NaCl, 10% (vol/vol) glycerol, 0.05% (vol/vol) Tween 20, 2 µM DTT and 0.5 mM TCEP, pH 7.1 was used. At pH 6.0, 150 mM MES was used instead of Hepes. Zn 2+ titrations were done by mixing 0.1-0.9 mM of Zn 2+ from a slightly acidic stock solution of ZnCl 2 99.99% (Acros) with buffering systems consisting of 1 mM EGTA, 1 mM HEDTA, 1 mM EDTA, 1 mM NTA or 1 mM 1,3-diamino-2-hydroxypropane-N,N,N′,N′-tetraacetic acid (DHPTA) (all from Sigma). For eCALWY-4, eCALWY-5 and eCALWY-6 titrations were also done by addition of 0.1-4.5 mM Zn 2+ to 5 mM EGTA. These buffering systems are referred to as the EGTA, the HEDTA, the EDTA, the DHPTA and the NTA buffering systems, respectively. The free zinc concentrations were calculated using the program MaxChelator using the stability constants present within the program (Supplementary Tables 3,4) . For DHTPA, calculations were done using log β values of 9.49, 6.96, 2.56 and 1.60 for H1, H2, H3 and H4, and log β values of 13.7 and 3.58 for the ML and MLH species, respectively 17 . All free zinc concentrations were calculated using T = 20 °C and ionic strength (I) = 0.1 M. Fluorescence spectra and emission anisotropy were recorded on a Varian Cary Eclipse spectrometer. Protein concentrations were determined by measuring the citrine absorbance at 515 nm using an extinction coefficient of 77,000 M −1 cm −1 (ref. 18 ). The Citrine/Cerulean (Cit/Cer) emission ratio was calculated by dividing the emissions at 527 and 475 nm, respectively. Dissociation constants were obtained by fitting the titration curves using Copper titrations. Stock solutions of (Cu + (CH 3 CN) 4 )(PF 6 ) were freshly prepared in acetonitrile. Copper titrations were performed in 100 mM MOPS, 100 mM NaCl and 10% (vol/vol) glycerol (pH 7.0). All manipulations and sample preparation were performed under an inert atmosphere and the protein samples were sealed in a cuvette with a rubber septum for fluorescence measurements.
Copper aliquots were added to the protein sample via a gas-tight Hamilton syringe. For eCALWY-1 and eCALWY-4, the samples were pretreated with excess DTT and EDTA for 1 h to reduce all cysteine residues and to chelate any Zn 2+ bound, respectively. The protein samples were then passed through a PD10 desalting column (GE Healthcare), pre-equilibrated with anaerobic MOPS buffer to remove all DTT. The protein was eluted and 1 mM EDTA added to the protein sample to inhibit Zn 2+ binding. Protein concentrations were determined by measuring the citrine absorbance at 515 nm using an extinction coefficient of 77,000 M −1 cm −1 (ref. 18 ). The Citrine/Cerulean ratio was calculated by dividing the emission intensities at 527 and 475 nm, respectively. For both eCALWY-1 and eCALWY-4, the copper titrations were performed by addition of 0.1-3.0 µM Cu + .
Cell culture. INS-1(832/13) cells were grown in RPMI-1640 medium containing 10% (vol/vol) FBS, 10 mM Hepes, 2 mM glutamine, 1 mM sodium-pyruvate, 50 µM β-mercaptoethanol, 100 units ml −1 penicillin and 100 µg ml −1 streptomycin at 37 °C in a humidified atmosphere containing 5% CO 2 . HEK293 cells were grown in DMEM (Sigma) containing 10% (vol/vol) FBS (Life Technologies), 3 mM glucose, 2 mM glutamine, 100 units ml −1 penicillin and 100 µg ml −1 streptomycin at the same temperature and CO 2 levels. Cells were plated on poly(L-lysine)-coated glass coverslips and transiently transfected with 0.5-1.0 µg of plasmid DNA by using Lipofectamine 2000 (Invitrogen) according to the manufacturers' instructions. Cells were imaged 2 d after transfection.
Intracellular FRET imaging.
Brightfield imaging was performed on an Olympus IX-70 microscope fitted with a monochromator (Polychrome IV; TILL Photonics) and an Imago charge-coupled device (CCD) camera (TILL Photonics) controlled by Tillvision software (TILL Photonics). For FRET measurements, a 455DRLP dichroic mirror (Chroma Technology) and two emission filters (Chroma; D465/30 for Cerulean and D535/30 for Citrine) alternated by a filter changer (Lambda 10-2; Sutter Instruments) were used. Images were acquired at 1 Hz using a 100-ms exposure time and a 433 nm excitation wavelength. Confocal images were made using a Zeiss Axiovert 200 M confocal microscope fitted with a PlanApo ×63 oil-immersion objective and a ×1.5 optivar.
Samples were illuminated at 440 and 561 nm for Cerulean and
